Journal
CURRENT OPINION IN IMMUNOLOGY
Volume 25, Issue 3, Pages 418-423Publisher
CURRENT BIOLOGY LTD
DOI: 10.1016/j.coi.2013.02.006
Keywords
-
Categories
Funding
- MRC
- Wellcome Trust
- BBSRC
- Diabetes UK
- JDRF
- MRC [G1001737] Funding Source: UKRI
- Medical Research Council [G1001737] Funding Source: researchfish
Ask authors/readers for more resources
There is an increasing interest in exploiting the immunomodulatory effects of helminths and their products in treatment of diseases such as allergy, autoimmunity and inflammatory bowel disease. Detailed examination of the ways in which helminth derived products interact with the host immune system and with host physiology has revealed that these may be multifaceted and have almost certainly arisen following co-evolution of helminths and their hosts. Clinical trials have been initiated with encouraging results in the treatment of inflammatory bowel disease and also Multiple Sclerosis. Identification of key pathways that are manipulated by helminths to ameliorate ongoing inflammatory conditions increases the prospect of developing novel therapies for the treatment and possible prevention of a range of debilitating and life threatening conditions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available